UiPath's competitive edge lies in its AI integration, SAP partnership and industry-agnostic automation solutions, making it a strong contender in RPA despite generative AI threats. Recent struggles ...

UiPath Inc. (NYSE:PATH) is one of the best mid cap AI stocks to buy right now. UiPath Inc. (NYSE:PATH) is one of the best midcap AI stocks to buy right now. On August 1, 2025, UiPath announced the ...

UiPath's share price has risen in recent months despite ongoing losses and slow growth. While market conditions are stable, there is still elevated deal scrutiny and longer sales cycles, particularly ...

UiPath launches AI-based Medical Record Summarization tool, reducing processing time from 45 minutes to minutes. Powered by Google Cloud, the agent improves accuracy, saves 40 minutes per referral, ...

NEW YORK & BOCA RATON, Fla.--(BUSINESS WIRE)--UiPath (NYSE: PATH), a leading enterprise automation and AI software company, today announced that it is transforming operations for Omega Healthcare, a ...

UiPath is dominating the robotic process automation market. Its tools can help businesses streamline their operations and cut costs. But it could face tough competition from newer generative AI ...